Related Experiment Video
Updated: Aug 11, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Risk management of tuberculosis in medical institutions]
1Japan Anti-Tuberculosis Association, 1-3-12, Misaki-cho, Chiyoda-ku, Tokyo 1010061, Japan. maoki@jatahq.org
Abstract:
As tuberculosis incidence is still high (23.3 per 100,000 in 2004) and infection control measures in hospitals are not so complete that about 8 or more nosocomial group infections are reported annually in these 10 years in Japan. Another reason of rather frequent occurring of group infection is that actual status of tuberculosis infection of medical staff remained unclear for long time because diagnosis of tuberculosis infection is almost impossible due to so wide and so long implementation of BCG vaccination in this country. To improve the present circumstances, the author has discussed on the recent theory and control measures of infection control introducing examples of nosocomial infections and results of studies carried out in many countries in these 10 years.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...